|
|
|
Volumn 24, Issue 4 SUPPL. 13, 1997, Pages
|
|
Docetaxel and paclitaxel in breast cancer therapy: Present status and future prospects
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DOCETAXEL;
DOXORUBICIN;
FLUOROURACIL;
GRANULOCYTE COLONY STIMULATING FACTOR;
MITOMYCIN;
MONOCLONAL ANTIBODY;
PACLITAXEL;
VINBLASTINE;
ANTINEOPLASTIC ACTIVITY;
BONE MARROW SUPPRESSION;
BREAST CANCER;
CANCER STAGING;
CLINICAL STUDY;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSS RESISTANCE;
DRUG RESISTANCE;
DRUG TOLERANCE;
EARLY DIAGNOSIS;
FOLLOW UP;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
METASTASIS;
MULTICENTER STUDY;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK ASSESSMENT;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CLINICAL TRIALS;
DRUG RESISTANCE;
FEMALE;
HUMANS;
PACLITAXEL;
TAXOIDS;
|
|
EID: 0030838814
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (32)
|
|
References (109)
|
